This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ moviprep (prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Bowel Preparation: Moviprep is highly effective in cleansing the bowel prior to colonoscopy or other diagnostic procedures. It helps remove fecal matter and residue from the colon, providing a clear view for the healthcare provider performing the procedure.

  2. Colonoscopy: Moviprep is commonly used before colonoscopy to ensure that the colon is adequately cleaned and free of any obstructions or debris. A clear colon allows the healthcare provider to visualize the intestinal lining and detect any abnormalities such as polyps, inflammation, or signs of colorectal cancer.

  3. Safety and Tolerability: Moviprep is generally safe and well-tolerated when used as directed. However, some individuals may experience side effects such as nausea, vomiting, abdominal discomfort, bloating, or dehydration during the bowel cleansing process. It's essential to follow the instructions provided by your healthcare provider and drink plenty of clear fluids to stay hydrated.

  4. Electrolyte Imbalance: Moviprep contains electrolytes such as potassium and sodium, which can be lost through diarrhea during bowel preparation. It's important to monitor electrolyte levels and stay hydrated during the cleansing process, especially for individuals with certain medical conditions such as kidney disease or heart failure.

  5. Medication Interactions: Moviprep may interact with certain medications, particularly those that affect electrolyte balance or gastrointestinal motility. It's important to inform your healthcare provider about all medications, supplements, and herbal products you are taking before starting Moviprep therapy.

  6. Contraindications: Moviprep may not be suitable for individuals with certain medical conditions, such as severe inflammatory bowel disease, bowel obstruction, or gastrointestinal perforation. It's important to discuss any underlying health conditions with your healthcare provider before using Moviprep.

  7. Pregnancy and Breastfeeding: The safety of Moviprep during pregnancy and breastfeeding has not been established. It's essential to discuss the potential risks and benefits of using Moviprep with your healthcare provider if you are pregnant or breastfeeding.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of moviprep (prescription) On Probiotics

Rank Probiotic Impact

Bacteria Impacted by moviprep (prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 delta/epsilon subdivisions clade Increases
0 1 Hydrogenophilia class Increases
0 1 Betaproteobacteria class Increases
0 1 Alphaproteobacteria class Increases
0 1 Acidithiobacillia class Increases
0 1 Oligoflexia class Increases
0 1 Zetaproteobacteria class Increases
0 1 Gammaproteobacteria class Increases
0 1 Fusobacteriia class Increases
1 0 Lachnospiraceae family Increases
0 1 Anaerotignum genus Increases
0 1 Anaeropeptidivorans genus Increases
0 1 Anaeromicropila genus Increases
0 1 Chordicoccus genus Increases
0 1 Tyzzerella genus Increases
0 1 Anaerocolumna genus Increases
0 1 Enterocloster genus Increases
0 1 Pseudobutyrivibrio genus Increases
0 1 Sporofaciens genus Increases
0 1 Lachnospira genus Increases
0 1 Wujia genus Increases
0 1 Simiaoa genus Increases
0 1 Sellimonas genus Increases
0 1 Herbinix genus Increases
0 1 Qiania genus Increases
0 1 Lacrimispora genus Increases
0 1 Novisyntrophococcus genus Increases
0 1 Lachnoanaerobaculum genus Increases
0 1 Butyrivibrio genus Increases
0 1 Mediterraneibacter genus Increases
0 1 Roseburia genus Increases
0 1 Lachnoclostridium genus Increases
0 1 Wansuia genus Increases
0 1 Abyssivirga genus Increases
0 1 Acetatifactor genus Increases
0 1 Acetitomaculum genus Increases
0 1 Agathobacter genus Increases
0 1 Anaerobium genus Increases
0 1 Anaerosacchariphilus genus Increases
0 1 Anaerosporobacter genus Increases
0 1 Anaerotaenia genus Increases
0 1 Anthropogastromicrobium genus Increases
0 1 Bariatricus genus Increases
0 1 Brotaphodocola genus Increases
0 1 Butyribacter genus Increases
0 1 Candidatus Epulonipiscium genus Increases
0 1 Catenibacillus genus Increases
0 1 Catonella genus Increases
0 1 Claveliimonas genus Increases
0 1 Cuneatibacter genus Increases
0 1 Diplocloster genus Increases
0 1 Eisenbergiella genus Increases
0 1 Extibacter genus Increases
0 1 Faecalicatena genus Increases
0 1 Faecalimonas genus Increases
0 1 Frisingicoccus genus Increases
0 1 Fusicatenibacter genus Increases
0 1 Gallintestinimicrobium genus Increases
0 1 Gluceribacter genus Increases
0 1 Hespellia genus Increases
0 1 Hominifimenecus genus Increases
0 1 Hominisplanchenecus genus Increases
0 1 Hoministercoradaptatus genus Increases
0 1 Hominiventricola genus Increases
0 1 Jingyaoa genus Increases
0 1 Johnsonella genus Increases
0 1 Jutongia genus Increases
0 1 Kineothrix genus Increases
0 1 Lachnobacterium genus Increases
0 1 Lachnotalea genus Increases
0 1 Lientehia genus Increases
0 1 Luxibacter genus Increases
0 1 Merdimonas genus Increases
0 1 Mobilitalea genus Increases
0 1 Moryella genus Increases
0 1 Muricomes genus Increases
0 1 Murimonas genus Increases
0 1 Niameybacter genus Increases
0 1 Oliverpabstia genus Increases
0 1 Oribacterium genus Increases
0 1 Parablautia genus Increases
0 1 Pararoseburia genus Increases
0 1 Parasporobacterium genus Increases
0 1 Porcincola genus Increases
0 1 Robinsoniella genus Increases
0 1 Schaedlerella genus Increases
0 1 Shuttleworthella genus Increases
0 1 Sporobacterium genus Increases
0 1 Stomatobaculum genus Increases
0 1 Suonthocola genus Increases
0 1 Syntrophococcus genus Increases
0 1 Waltera genus Increases
0 1 Zhenhengia genus Increases
0 1 Marvinbryantia genus Increases
0 1 Coprococcus genus Increases
0 1 Anaerostipes genus Increases
0 1 Anaerobutyricum genus Increases
0 1 Blautia genus Increases
0 1 Cellulosilyticum genus Increases
1 0 Dorea genus Increases
0 1 environmental samples no rank Increases
0 1 environmental samples no rank Increases
0 1 environmental samples no rank Increases
0 1 environmental samples no rank Increases
0 1 Lachnospiraceae incertae sedis no rank Increases
0 1 Pseudomonadota incertae sedis no rank Increases
0 1 unclassified Dorea no rank Increases
0 1 unclassified Fusobacteriota no rank Increases
0 1 unclassified Lachnospiraceae no rank Increases
0 1 unclassified Pseudomonadota no rank Increases
0 1 Eubacteriales order Increases
1 0 Fusobacteriota phylum Increases
1 0 Pseudomonadota phylum Increases
0 1 Candidatus Dorea faecipullorum species Increases
0 1 Candidatus Dorea massiliensis species Increases
0 1 Candidatus Dorea merdavium species Increases
0 1 Dorea hominis species Increases
0 1 Dorea phocaeensis species Increases
0 1 Dorea sp. species Increases
0 1 Dorea sp. AGR2135 species Increases
0 1 Dorea sp. AM13-35 species Increases
0 1 Dorea sp. AM58-8 species Increases
0 1 Dorea sp. MC_33 species Increases
0 1 Dorea longicatena species Increases
1 0 Dorea formicigenerans species Increases
0 1 Dorea formicigenerans 4_6_53AFAA strain Increases
0 1 Dorea formicigenerans ATCC 27755 strain Increases

Impact of moviprep (prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 1.2 1.2 0
ADHD 1.5 2 -0.33
Age-Related Macular Degeneration and Glaucoma 0.6 0.9 -0.5
Allergic Rhinitis (Hay Fever) 1.2 1 0.2
Allergies 0.9 1.9 -1.11
Allergy to milk products 1.2 0.9 0.33
Alopecia (Hair Loss) 2.6 -2.6
Alzheimer's disease 3 2.9 0.03
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.6 2.7 -3.5
Ankylosing spondylitis 0.7 2.6 -2.71
Anorexia Nervosa 2.9 1.3 1.23
Asthma 1.4 2.6 -0.86
Atherosclerosis 0.3 0.3
Atrial fibrillation 1.3 2.5 -0.92
Autism 5.4 4.1 0.32
Autoimmune Disease 0.3 0.1 2
Barrett esophagus cancer 0.6 -0.6
benign prostatic hyperplasia 0.3 0.3
Bipolar Disorder 1.2 0.3 3
Brain Trauma 0.3 0.9 -2
Breast Cancer 0.7 -0.7
Cancer (General) 0.6 -0.6
Carcinoma 1.3 1.5 -0.15
Celiac Disease 3.6 1.5 1.4
Cerebral Palsy 1 1
Chronic Fatigue Syndrome 3.3 1.5 1.2
Chronic Kidney Disease 1.7 1.2 0.42
Chronic Lyme 0.3 0.3
Chronic Obstructive Pulmonary Disease (COPD) 1.3 2.1 -0.62
Chronic Urticaria (Hives) 0.3 0.6 -1
Coagulation / Micro clot triggering bacteria 2 2
Cognitive Function 0.6 2.3 -2.83
Colorectal Cancer 1.5 3 -1
Constipation 0.7 1.9 -1.71
Coronary artery disease 2.5 1.2 1.08
COVID-19 6.6 4 0.65
Crohn's Disease 3.8 3.6 0.06
cystic fibrosis 0.7 0.7
deep vein thrombosis 1.3 1.6 -0.23
Denture Wearers Oral Shifts 0.3 -0.3
Depression 5.7 5.9 -0.04
Dermatomyositis 1 -1
Endometriosis 1 1.9 -0.9
Eosinophilic Esophagitis 0.3 0.6 -1
Epilepsy 1 3.4 -2.4
erectile dysfunction 1 -1
Fibromyalgia 0.6 1.9 -2.17
Functional constipation / chronic idiopathic constipation 2 2.6 -0.3
gallstone disease (gsd) 0.3 2 -5.67
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.1 2.1 -0.91
Generalized anxiety disorder 1.4 1.7 -0.21
Glioblastoma 0.9 0.9
Gout 0.9 0.9
Graves' disease 2.8 0.3 8.33
Gulf War Syndrome 0.6 1.6 -1.67
Halitosis 0.6 0.3 1
Hashimoto's thyroiditis 0.7 2.8 -3
Heart Failure 2.9 1.4 1.07
hemorrhagic stroke 0.3 2.1 -6
Hidradenitis Suppurativa 0.6 0.1 5
High Histamine/low DAO 0.3 0.3 0
hypercholesterolemia (High Cholesterol) 0.3 -0.3
hyperglycemia 0.4 0.6 -0.5
Hyperlipidemia (High Blood Fats) 0.6 1.1 -0.83
hypersomnia 1 0 0
hypertension (High Blood Pressure 2.7 4.8 -0.78
Hypothyroidism 2.2 0.2 10
Hypoxia 0.6 -0.6
IgA nephropathy (IgAN) 1.2 0.6 1
Inflammatory Bowel Disease 3 1.7 0.76
Insomnia 1.7 2.5 -0.47
Intelligence 1.2 -1.2
Intracranial aneurysms 1.6 1.3 0.23
Irritable Bowel Syndrome 1.6 4.8 -2
ischemic stroke 1.7 0.7 1.43
Juvenile idiopathic arthritis 0.6 -0.6
Liver Cirrhosis 1.5 4.3 -1.87
Long COVID 4.2 5.1 -0.21
Low bone mineral density 1.3 0.5 1.6
Lung Cancer 1.9 1.9
Mast Cell Issues / mastitis 1.8 0.6 2
ME/CFS with IBS 1.2 1.2
ME/CFS without IBS 1.2 0.6 1
Menopause 0.3 0.3
Metabolic Syndrome 3.6 4.2 -0.17
Mood Disorders 5 4.4 0.14
multiple chemical sensitivity [MCS] 0.4 0.4
Multiple Sclerosis 2.5 1.6 0.56
Multiple system atrophy (MSA) 0.4 0.4
myasthenia gravis 0.8 0.9 -0.13
neuropathic pain 1 1
Neuropathy (all types) 1.5 1.3 0.15
neuropsychiatric disorders (PANDAS, PANS) 0.6 0.6
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2.7 4.9 -0.81
NonCeliac Gluten Sensitivity 1 -1
Obesity 3.5 5.5 -0.57
obsessive-compulsive disorder 3.5 1 2.5
Osteoarthritis 1 -1
Osteoporosis 1.4 2.1 -0.5
pancreatic cancer 0.6 0.6
Parkinson's Disease 4.4 3.1 0.42
Peanut Allergy 0.6 0.6
Polycystic ovary syndrome 1.7 3 -0.76
Postural orthostatic tachycardia syndrome 0.3 0.3 0
Premenstrual dysphoric disorder 0.3 0.7 -1.33
primary biliary cholangitis 1.2 -1.2
Primary sclerosing cholangitis 2.2 2.4 -0.09
Psoriasis 0.7 1 -0.43
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 2.9 4.7 -0.62
Rosacea 0.9 0.6 0.5
Schizophrenia 3 4.2 -0.4
scoliosis 0.9 -0.9
sensorineural hearing loss 0.6 0.6
Sjögren syndrome 2.5 0.5 4
Sleep Apnea 1.3 2 -0.54
Small Intestinal Bacterial Overgrowth (SIBO) 0.6 -0.6
Stress / posttraumatic stress disorder 1.2 1.7 -0.42
Systemic Lupus Erythematosus 3.3 2.2 0.5
Tic Disorder 0.6 0.6
Tourette syndrome 0.6 -0.6
Type 1 Diabetes 1 2.3 -1.3
Type 2 Diabetes 3.8 4.8 -0.26
Ulcerative colitis 2 4.1 -1.05
Unhealthy Ageing 0.8 0.9 -0.13
Vitiligo 0.3 1.3 -3.33

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]